Clinical Trials Browser

Phase 2 × Active not recruiting × Lung Cancer Metastatic × Clear all

NCT03057106 2026-03-03

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Phase 2 Active not recruiting

301 enrolled 15 charts

Lung Cancer Metastatic

NCT05144529 2025-04-17

TOP2101

Phase 2 Active not recruiting

Lung Cancer Metastatic